Stoltmann Law Offices is investigating potential claims on behalf of investors who may have invested in purchases of the securities of Neovasc Inc., during the period between January 26, 2015 and May 19th, 2016. On May 19th, 2016, news sources reported that a Massachusetts federal jury had reached a judgment and awarded $70 million to Neovasc’s rival company, CardiAQ Valve Technologies Inc. (CardiAQ). A jury found that Neovasc had stolen trade secrets from CardiAQ Valve Technologies Inc. Please contact our Chicago-based law offices if you invested with Neovasc Inc. We are securities attorneys who may be able to help you recover your investment losses in the Financial Industry Regulatory Authority (FINRA) arbitration forum on a contingency fee basis. The call is free with no obligation. Please call today. 312-332-4200.
Let Us Get Your